Theorem Clinical Research

INC Research

ACRO holds initial meeting of CRO Forum

Wednesday, March 18, 2015 01:21 PM

The Association of Clinical Research Organizations (ACRO) has held the inaugural meeting of the CRO Forum in Washington, D.C. The Forum was established last October as the primary vehicle for interaction between the CRO industry and TransCelerate BioPharma.

More... »

Quest Diagnostics

PharmaTimes clinical research awards to be presented Feb. 26

Thursday, February 12, 2015 03:33 PM

The 2015’s PharmaTimes Clinical Researcher of the Year—The Americas awards will be presented Feb. 26 in North Carolina.

More... »


INC enhances clinical delivery focus with executive leadership promotions

Thursday, January 22, 2015 01:38 PM

INC Research Holdings, a, global phase I to IV CRO based in Raleigh, N.C., has announced the promotions of Alistair Macdonald and Michael Gibertini, Ph.D., to key roles within the C-suite.

More... »

INC Research expands relationship with Society for Clinical Research Sites

Friday, December 5, 2014 12:36 PM

INC Research Holdings, a global phase I-IV CRO headquartered in Raleigh, N.C., has announced an expanded partnership with the Society for Clinical Research Sites (SCRS), an Ellicott City, Md.-based global trade organization, to become the society’s first Circle of Sustainability Sponsor, reinforcing the INC’s commitment to fostering strong site relationships globally.

More... »

Clinverse names John Musante chief commercial officer

Monday, November 24, 2014 02:34 PM

Clinverse, a provider of automated financial management technology solutions for clinical trials, has added John Musante as chief commercial officer. Musante brings more than 25 years of experience across industry sectors including health care, technology, and life sciences.

More... »

PRA Health Sciences becomes latest big CRO to launch IPO

Thursday, November 13, 2014 03:38 PM

PRA Health Sciences launched its initial public offering this morning, raising $306 million from the sale of nearly 17 million shares at $18 per share—below plans it announced in September to raise up to $375 million.

More... »

INC Research launches its IPO

Monday, November 10, 2014 02:38 PM

Global CRO INC Research launched its initial public offering today, raising $150 million by selling just over 8.1 million shares at $18.50 per share—the middle of the expected $17-$20 range. The stock climbed 9% in early trading past $20.75 before settling to $20 by late afternoon.

More... »

INC Research to perform FDA due diligence audit for Provectus

Thursday, October 23, 2014 01:10 PM

Provectus Biopharmaceuticals, a Knoxville, Tenn.-based development-stage oncology and dermatology biopharmaceutical company, has retained INC Research, a Raleigh, N.C.-based global CRO, to conduct an FDA due diligence audit of its regulatory documents for PH-10 and PV-10.

More... »

INC Research files for initial public offering

Tuesday, October 7, 2014 12:27 PM

INC Research Holdings, which has spent the past two decades acquiring 10 companies, has announced plans for an initial public offering expected to raise $150 million.

More... »

New ACRO survey: CRO members saw big growth in past decade

Friday, September 19, 2014 03:34 PM

The biopharmaceutical industry’s outsourcing strategy has enabled the eight members of the Association of Clinical Research Organizations (ACRO) to double in size over the past 10 years, today employing more than 100,000 professionals worldwide with a global payroll of nearly $6 billion.

More... »


CWWeekly

March 23

Industry welcomes FDA draft guidance outlining the use of electronic Informed Consent for trials

Apple launches ResearchKit platform to tap millions of iPhone users to enroll in observational studies using apps

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs